	Performance of percutaneous core biopsy in predicting renal tumour pathology: a systematic review. BJU Int Stokes R, Hennessey D, Kinnear N. PMID: 41269070 [PubMed - as supplied by publisher]
	Association Between a Co-Designed Dashboard and Use of Costly Health Services in Patients With Chronic Kidney Disease and Advanced Cancer: Propensity Score-Adjusted Difference-in-Differences Study. J Med Internet Res Amagai S, Harris A, Mohindra N, Kircher S, Linder JA, Aggarwal V, Peipert JD, Bedjeti K, Mai Q, Barnard C, Coughlin A, O'Connor M, Morken V, Cella D, Jordan N. PMID: 41268967 [PubMed - indexed for MEDLINE]
	MYC variant at 8q24 increases susceptibility to urinary bladder cancer: a meta-analysis of 53,957 individuals. Per Med de Moraes FCA, Rego LHRM, Morbach V, de Lima MPP, Burbano RMR. PMID: 41268746 [PubMed - as supplied by publisher]
	Neoadjuvant tislelizumab plus pazopanib in renal cell carcinoma with venous tumour thrombus: A retrospective study. BJUI Compass Dilixiati D, Li H, Chen H, Xie S, Aihemaiti N, Abulimiti G, Azhati B. PMID: 41268304 [PubMed]
	Circulating Tumor Cells and Clinical Outcomes in Men with Metastatic Castration-sensitive Prostate Cancer Treated with Enzalutamide and Docetaxel: An Analysis of the ENZADA Trial. Eur Urol Open Sci Brown LC, Boselli D, Symanowski JT, Grigg CM, Zhu J, Norek S, Begic XJ, Raghavan D, Burgess EF. PMID: 41268104 [PubMed]
	Clinical Effectiveness of Oral Relugolix in Advanced Prostate Cancer: A Structured Review of Current Primary Research. Cureus Higgi A, Melvin C, Abdelrasheed A, Wilson K. PMID: 41268025 [PubMed]
	Prognostic value of the GRANT score and development of a nomogram in papillary renal cell carcinoma: a SEER-based study with external validation in a Chinese cohort. Front Oncol Liu T, Chen W, Yao Y, Hu Y, Sun L, Zhang G. PMID: 41267977 [PubMed]
	Diagnostic Accuracy of Fully Hybrid PET/MRI with [(68)Ga]Ga-PSMA-11 and [(68)Ga]Ga-RM2 in Detecting Primary Prostate Cancer: A Phase 2 Trial with Histology as Gold Standard. J Nucl Med Ghezzo S, Mapelli P, Cogrossi LL, Samanes Gajate AM, Brembilla G, Cucchiara V, Mattorre B, Russo T, Bezzi C, Neri I, Vadalà S, Alimonti A, Freschi M, Briganti A, De Cobelli F, Chiti A, Bellone M, Scifo P, Picchio M. PMID: 41266247 [PubMed - as supplied by publisher]
	A Transformer-Based Model Integrating Intratumoral Habitats and Peritumoral Radiomics for Detecting Pelvic Lymph Node Metastasis in Prostate Cancer. Acad Radiol Cao J, Feng X, Liu R, Luo T, Yang L, Li H, Wang F, Lin P, Xiang Y, Yang J, Fu Y, Li F. PMID: 41266221 [PubMed - as supplied by publisher]
	CaboPoint and the Future of Renal Cell Carcinoma Trials: Sequencing, Biomarkers, and Strategy. Eur Urol Khosla AA, Moradi A, Jatwani K. PMID: 41266219 [PubMed - as supplied by publisher]
	Real-World Treatment Patterns and Survival in Metastatic Castration-resistant Prostate Cancer: A Systematic Review of Observational Studies. Eur Urol Focus Raval AD, Queen V, Korn MJ, Quintero V, Freedland SJ. PMID: 41266184 [PubMed - as supplied by publisher]
	Single dose perioperative intravesical instillation of gemcitabine versus mitomycin-C following resection of non-muscle invasive bladder cancer: A randomized controlled trial. Urol Oncol Arulraj K, Aggarwal N, Nayak B, Nayyar R, Kumar R, Seth A. PMID: 41266181 [PubMed - as supplied by publisher]
	Comparative prognostic performance of KEYNOTE-564 and AUA risk stratification in nonmetastatic clear cell renal cell carcinoma. Urol Oncol Garofano G, Saitta C, Musso G, Meagher MF, Saita A, Lazzeri M, Capitanio U, Dabbas M, Larcher A, Autorino R, Pandolfo SD, Patil D, Saito K, Yasuda Y, Tanaka H, Fontana G, Montorsi F, Lughezzani G, Casale P, Fujii Y, Master VA, Buffi NM, Campbell SC, Derweesh IH. PMID: 41266180 [PubMed - as supplied by publisher]
	ETS-related gene as a key factor in curcumin inhibition of glucose metabolism in prostate cancer cells: an in vitro experimental study. J Yeungnam Med Sci Wang Y, Zhao X, Zhao J, Wang X, Guo Y, Chen S, Jin Y, Peng P, Zhang W. PMID: 41266092 [PubMed]
	Active Surveillance for Prostate Cancer. Urol Clin North Am Klotz L. PMID: 41266006 [PubMed - indexed for MEDLINE]
	Gleason Grade Group 1 Prostate Cancer: Arguments for and Against a Cancer Designation. Urol Clin North Am Dall CP, Hirsch MS, Kibel AS, Cole AP. PMID: 41266005 [PubMed - indexed for MEDLINE]
	Should Gleason 6 Still Be Considered Cancer? A Narrative Review of its Biology and Clinical Course, with Implications for Guideline Recommendations and Practice Implementation. Urol Clin North Am Yao B, Wilt T, Dahm P. PMID: 41266004 [PubMed - indexed for MEDLINE]
	Imaging of Clinically Localized Prostate Cancer. Urol Clin North Am Walia AS, Huang W. PMID: 41266003 [PubMed - indexed for MEDLINE]
	The Role of Genetic Testing in Localized Prostate Cancer. Urol Clin North Am Sager RA, Bratslavsky G. PMID: 41266002 [PubMed - indexed for MEDLINE]
	Prostate Cancer Grading: An Update. Urol Clin North Am Hanna J, Bratslavsky G, Cheng L, Ross JS, Kravtsov O. PMID: 41266001 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 280257

Page 1 of 14013



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy